Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observer-blind, Randomized, Controlled Study to Determine the Immunogenicity and Safety of a Two-dose Regimen of Virosomal Subunit Influenza Vaccine Inflexal V in Healthy Young Children (≥6 Months to ≤35 Months) in Comparison With the Subunit Influenza Vaccine Agrippal

NCT01310400 is registered in ClinicalTrials.gov with Crucell Holland BV as lead sponsor.

NCT NCT01310400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01310400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observer-blind, Randomized, Controlled Study to Determine the Immunogenicity and Safety of a Two-dose Regimen of Virosomal Subunit Influenza Vaccine Inflexal V in Healthy Young Children (≥6 Months to ≤35 Months) in Comparison With the Subunit Influenza Vaccine Agrippal
Lead sponsor
Crucell Holland BV
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
January 31, 2010
Enrollment
1,356 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza